BIOTHERYX, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.biotheryx.com
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced And/or Metastatic Breast Cancer
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Biotheryx, Inc.
- Target Recruit Count
- 82
- Registration Number
- NCT06515470
- Locations
- 🇺🇸
Biotheryx Investigative Site, San Antonio, Texas, United States
A Study of BTX-1188 in Subjects With Advanced Malignancies
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Biotheryx, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT05144334
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
© Copyright 2024. All Rights Reserved by MedPath